• Hennig Arzneimittel is a highly-recognised specialist in manufacturing and marketing of both prescription and OTC pharmaceutical preparations with its own direct sales force in Germany
• Polifarma, a medium-sized pharmaceutical company from Italy and long-standing partner of Hennig, is expanding its market position in Germany with the acquisition, achieving synergies in production and distribution
• RSM Ebner Stolz exclusively advised the private owners of Hennig with an interdisciplinary team of M&A-, legal- and transaction advisors

Frankfurt am Main, February 17^th 2025 - On behalf of the shareholders of Hennig Arzneimittel GmbH & Co. KG, RSM Ebner Stolz exclusively led the successful search for a successor and supported the sell side as M&A- and legal advisors. The buyer is the Italian company Polifarma S.p.A., which is also family-owned and based in Rome.

Hennig Arzneimittel GmbH & Co. KG has been operating as a medium-sized, family-owned pharmaceutical company for more than 125 years and specialises in the sale of original preparations, generics and OTC products for the treatment of vertigo and other neurological indications. Of further importance are various export markets in which Hennig has established long-term partnerships with local distributors. The company's sustained success is also based on a diversified product portfolio for other disease areas, including indications such as sleep disorders, pain therapy and high blood pressure, as well as head lice and warts, which are primarily sold on the German market. Hennig also operates as a contract manufacturer, utilizing its expertise in specialised retard and pulsatile solutions for solid dosage forms and its modern and flexible production facilities.

The buyer, Polifarma S.p.A., is a long-standing partner of Hennig Arzneimittel for the Italian market. The company, with a history of more than one hundred years, is part of the diversified Final Group, which comprises the main business activities of the Angelini family. Polifarma offers regional and international preparations for diseases of the central nervous system, gastroenterology, ophthalmology, cardiology and various other infectious diseases. Another area of focus is R&D, especially for bio-digital solutions.

RSM Ebner Stolz was exclusively tasked to lead the sales process of Hennig Arzneimittel GmbH & Co. KG. A team led by industry experts Alexander Wenzel and Pranshu Rohatgi was responsible for the successful investor search and management of the complete M&A process. The interdisciplinary co-operation between various service offerings from RSM Ebner Stolz contributed decisively to the success of the project. In addition to providing M&A advice, a legal team led by Dr. Roderich Fischer and Sascha Meloh provided legal advice, while colleagues from the transaction advisory team surrounding Matthias Krankowsky and Henrik Merz supported the sellers with a financial fact book.

Polifarma was assisted by Deloitte Financial Advisory as exclusive Financial Advisor. The project was carried out by a team composed of partner Elio Milantoni, senior manager Giuseppe Diana, assistant manager Paolo Gambogi, and associate Olivier Vellucci for M&A aspects, while partner Luigi Cutugno and senior manager Simone Beretta focused on debt advisory. EY Law acted as legal advisor to Polifarma S.p.A. with a team led by partners Francesco Aratari and Luca Iannaccone, and counsel Sara Reverso.

The parties have agreed not to disclose the financial terms of the transaction.

Team RSM Ebner Stolz M&A: Alexander Wenzel (Project Responsible Partner), Pranshu Rohatgi (Co-Project Leader), Philipp Dille (Co-Project Leader), and Jan Schüttert (all M&A Advisory, RSM Ebner Stolz Management Consultants), Dr. Roderich Fischer (Project Responsible Partner, Corporate/M&A Legal), Sascha Meloh, Tessa Treiber (both Corporate/M&A Legal), Laurent Meister (Partner, IP/IT), Philipp Stürmer (IP/IT), Anh Ngoc Heimbach (Labor Law), Dr. Alexander Rehs (Public Law), Matthias Krankowsky (Project Responsible Partner, Transaction Advisory Services), Henrik Merz, Yasir Niaz Butt, Filippo Sztaray, Moritz Klapczynski (all Financial Fact Book).

About RSM Ebner Stolz

RSM Ebner Stolz is one of the largest independent medium-sized auditing and consulting firms in Germany. The company is among the top ten in the industry and has extensive expertise in auditing, tax, legal, and management consulting. With this multidisciplinary consulting approach and over 2,400 employees at 14 locations, RSM Ebner Stolz, as a market leader in the mid-sized sector, serves national and international industrial, commercial, and service companies from all industries.

As a member of RSM International, RSM Ebner Stolz offers its clients high-quality auditing and consulting services in 120 countries worldwide through 820 offices.